| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | INSP Inspire Medical Systems, Inc. | McCormick Shawn78 | Director | Sell | 800 | $220.00 | $176,000.00 | -3.3% | -10.4% | -61.5% | |
| Sep 9, 2024 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $246.42 | $246,420.00 | -1.0% | -1.9% | +11.9% | |
| Sep 9, 2024 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 77,143 | $13.58 | $1,047,483.74 | -67.6% | +68.9% | +93.8% | |
| Sep 6, 2024 | SERA Sera Prognostics, Inc. | Mirza Mansoor Raza79 | Director | Sell | 96 | $7.16 | $687.36 | -1.4% | +0.7% | -53.9% | |
| Sep 6, 2024 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 15,272 | $13.00 | $198,536.00 | -7.7% | +77.6% | +98.6% | |
| Sep 6, 2024 | IDXX Idexx Laboratories Inc /de | Szostak M Anne | Director | Sell | 500 | $469.37 | $234,686.15 | -100% | -9.5% | +36.1% | |
| Sep 5, 2024 | ZOMDF Zomedica Corp. | Heaton Larry C II | CEO | Buy | 100,000 | $0.13 | $12,500.00 | +33.3% | - | - | |
| Sep 5, 2024 | COO Cooper Companies, Inc. | Andrews Brian G70 | EVP, CFO &Treasurer | Sell | 24,788 | $105.90 | $2,625,071.51 | -78.9% | -1.4% | -36.1% | |
| Sep 5, 2024 | STIM Neuronetics, Inc. | Muir Glenn P80 | Director | Buy | 25,000 | $0.80 | $20,000.00 | +9.4% | +50.0% | +312.5% | |
| Sep 5, 2024 | AVTR Avantor, Inc. | Eck Steven W67 | SVP &Chief Accounting Officer | Sell | 3,525 | $25.06 | $88,336.50 | -10.7% | -17.4% | -48.1% | |
| Sep 5, 2024 | MYO Myomo, Inc. | Kovelman Harry68 | Chief Medical Officer | Sell | 6,700 | $3.76 | $25,182.62 | -5.1% | +41.9% | -73.5% | |
| Sep 5, 2024 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 162,777 | $81.17 | $13,212,543.98 | -9.1% | +11.6% | +31.8% | |
| Sep 5, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 5,251 | $0.91 | $4,799.41 | - | -30.0% | -13.3% | |
| Sep 5, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 10,212 | $1.70 | $17,319.55 | -0.7% | +99.4% | -6.0% | |
| Sep 5, 2024 | PRCT Procept Biorobotics Corp | Desai Antal Rohit82 | Director | Sell | 102,157 | $75.78 | $7,741,893.10 | -5.3% | +30.3% | -46.7% | |
| Sep 4, 2024 | ARAY Accuray Inc | Pervaiz Ali63 | SVP Chief Financial Officer | Sell | 8,404 | $2.06 | $17,276.10 | -2.1% | +4.0% | -25.2% | |
| Sep 4, 2024 | PEN Penumbra Inc | Grewal Harpreet60 | Director | Sell | 782 | $204.11 | $159,614.02 | -8.1% | +21.1% | +38.1% | |
| Sep 4, 2024 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 2,000 | $239.90 | $479,800.00 | -2.2% | +0.9% | +11.9% | |
| Sep 4, 2024 | COO Cooper Companies, Inc. | McBride Daniel G70 | EVP &Chief Operating Officer | Sell | 114,992 | $105.48 | $12,129,910.99 | -41.4% | -2.1% | -35.6% | |
| Sep 4, 2024 | CERS Cerus Corp | Green Kevin Dennis71 | Chief Financial Officer | Sell | 82,657 | $2.16 | $178,744.95 | -6.8% | -16.1% | -37.0% | |
| Sep 4, 2024 | MXCT Maxcyte, Inc. | Erck Stanley C86 | Director | Sell | 47,689 | $4.02 | $191,655.19 | -8.1% | -8.2% | -65.1% | |
| Sep 4, 2024 | ABT Abbott Laboratories | McCoy John A. Jr.45 | Vice President | Sell | 27 | $114.83 | $3,100.41 | -0.1% | +1.7% | +16.1% | |
| Sep 3, 2024 | ICUI Icu Medical Inc/de | Jain Vivek83 | Chairman And CEO | Sell | 12,000 | $163.46 | $1,961,540.40 | -3.7% | -1.3% | -23.9% | |
| Sep 3, 2024 | RBOT Vicarious Surgical Inc. | Mazzola John71 | Chief Operating Officer | Sell | 195 | $5.82 | $1,134.72 | -1.9% | +113.9% | 0.0% | |
| Sep 3, 2024 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 1,414 | $16.35 | $23,118.90 | -0.7% | -16.1% | +1.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.